Intracranial germ cell tumors

Oncologist

Volumn 5, Issue 4, 2000, Pages 312-320

  Packer, R J ^a   Cohen, B H ^a   Coney, K ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

Chemotherapy; Embryonal carcinoma; Germinoma; Intracranial germ cell tumor; Mixed germ cell tumor; Nongerminomatous germ cell tumor; Radiation therapy; Teratoma

Indexed keywords

ALKALINE PHOSPHATASE PLACENTA ISOENZYME; ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; IFOSFAMIDE; TUMOR MARKER; VINBLASTINE;

ARTICLE; BRAIN RADIATION; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CHORIOCARCINOMA; CLINICAL FEATURE; EMBRYONAL CARCINOMA; GERM CELL TUMOR; HISTOPATHOLOGY; HUMAN; INTRACRANIAL TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; SKULL IRRADIATION; SURVIVAL RATE; TERATOMA; TUMOR CLASSIFICATION; YOLK SAC TUMOR;

EID: 0033850029     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.2000-0312     Document Type: Article

References (63)

1. Intracranial germ-cell tumors: Natural history and pathogenesis
2. Statistical reevalulation of pinealoma and related tumors in Japan
3. Pineal region masses, selection of an operative approach
4. Supracerebellar approaches in the pineal region
5. Ultrastructure study of intracranial yolk sac tumor: With special reference to the oncologic phylogeny of germ-cell tumors
6. So-called intracranial germ-cell tumours: Personal experiences and a theory of their pathogenesis
7. Alphafetoprotein and human chorionic gonadotropin determination in cerebrospinal fluid: An aid to the diagnosis and management of intracranial germ-cell tumors
8. Alpha-feto-protein (AFP) and human chorionic gonadotropin (HCG) as biochemical markers of intracranial germ cell tumours
9. Human chorionic gonadotropin-beta subunit gene expression in cultured human fetal and cancer cells of different types and origins
10. Placental alkaline phosphatase as a tumor marker for primary intracranial germinoma
11. Pineal region tumors of childhood
12. Suprasellar germinomas in childhood: A reappraisal
13. Endocrine aspects and tumoral markers in intracranial germinoma: An attempt to delineate the diagnostic procedure in 14 patients
14. Computed tomography of pineal, peripineal and histologically related tumor
15. MR imaging of pineal tumors
16. Assessment and management of pineal-region and related tumors
17. Pineal region masses: Differential diagnosis
18. Radiation therapy of intracranial germ-cell tumors with radiosensitivity assessment
19. Controversies in the management of intracranial germ-cell tumors
20. Pineal region tumours of childhood
21. The role of cerebrospinal fluid cytology in radiotherapy planning for intracranial germinoma
22. Management of primary intracranial germinomas: Diagnostic surgery or radical resection?
23. Primary intracranial germ cell tumors: A clinical analysis of 153 histologically verified cases
24. Germ cell tumours of the central nervous system: Treatment consideration based on 111 cases and their long-term clinical outcomes
25. Prognosis of intracranial germinoma with syncytiotrophoblastic giant cells treated by radiation therapy
26. Human chorionic gonadotrophin in CSF, not serum, predicts outcome in germinoma
27. An attempt to treat pediatric intracranial alphaFP and betaHCG secreting germ cell tumors with chemotherapy alone. SFOP experience with 18 cases
28. Combined treatment modality for intracranial germinomas: Results of a multicentre SFOP experience
29. Pineal region germinomas in childhood: Treatment considerations
30. Midline pineal tumors and suprasellar germinomas: Highly curable by irradiation
31. Tumors of the pineal and suprasellar region: Children's cancer study group treatment results 1960-1975
32. Treatments and prognosis of pineal tumors: Experience of 100 cases
33. Pineal and ectopic pineal tumors: The role of radiation therapy
34. Pinealoma (germinoma) treated by direct surgery and post-operative irradiation
35. Suprasellar germinoma: Radiation therapy
36. Treatment results of intracranial germinoma as a function of the irradiated volume
37. Radiation therapy for histologically confirmed primary central nervous system germinoma
38. Radiotherapy of intracranial germinomas
39. Intracranial germinoma: The case for lower dose radiation therapy
40. Quality of life of adult survivors of germinomas treated with craniospinal irradiation
41. The treatment of stage III metastatic germinal neoplasia of the testis with bleomycin combination therapy
42. A clinical review of bleomycina - A new antineoplastic agent
43. Advanced seminoma treatment with cis-platin based chemotherapy or carboplatin
44. Evaluation of optimal combination of chemotherapy in favorable prognosis disseminated germ-cell tumors: A Southeastern Cancer Study group protocol
45. Disseminated testis cancer: Approaching the next decade
46. Treatment of disseminated germ-cell tumors with cisplatin, bleomycin and either vinblastine or etoposide
47. Neoadjuvant chemotherapy for newly-diagnosed germ-cell tumors of the CNS
48. A phase II trial of preirradiation carboplatin in newly diagnosed germinoma of the central nervous system
49. Nonmetastatic intracranial germinoma: The experience of the French society of pediatric oncology
50. Induction chemotherapy followed by reduced-volume radiation therapy for newly diagnosed central nervous system germinoma
51. Chemotherapy without irradiation: A novel approach for newly-diagnosed central nervous system (CNS) germ-cell tumors (GCT) results of an international cooperative trial
52. Treatment of intracranial nongerminomatous malignant germ cell tumors in children: The role of each treatment modality
53. Controversies in the management of intracranial germ cell tumors
54. Chemotherapy trials in recurrent primary intracranial germ cell tumors
55. Prognosis of intracranial germ cell tumors: Effectiveness of chemotherapy with cisplatin and etoposide (CDDP and VP-16)
56. Combination chemotherapy with vinblastine, bleomycin, cisplatin, and etoposide (VBPE) in children with primary intracranial germ cell tumors
57. Preliminary observations for a new treatment in children with primary intracranial yolk sac tumor or embryonal carcinoma
58. Phase II trial of primary chemotherapy followed by reduced-dose radiation for CNS germ cell tumors
59. Safety and efficacy of a multicenter study using inraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors
60. Treatment of intracranial nongerminomatous germ-cell tumor by high-dose chemotherapy and autologous stem-cell rescue